Emerald Health Therapeutics, Inc. (CVE:EMH – Get Free Report)’s share price traded down 3.8% during trading on Tuesday . The company traded as low as C$0.25 and last traded at C$0.26. 384,329 shares traded hands during trading, a decline of 40% from the average session volume of 644,760 shares. The stock had previously closed at C$0.27.
Emerald Health Therapeutics Stock Performance
The firm has a market capitalization of C$52.28 million and a price-to-earnings ratio of -0.37. The company has a quick ratio of 2.61, a current ratio of 2.97 and a debt-to-equity ratio of 35.45. The stock has a 50-day moving average price of C$0.26 and a 200 day moving average price of C$0.26.
Emerald Health Therapeutics Company Profile
Emerald Health Therapeutics, Inc, together with its subsidiaries, produces and sells medical cannabis for medical purpose in Canada. The company is also involved in developing natural health products. It offers dried cannabis strains, pre-rolls, and cannabis oil products to its medical patients. The company was formerly known as T-Bird Pharma Inc and changed its name to Emerald Health Therapeutics, Inc in June 2015.
Further Reading
- Five stocks we like better than Emerald Health Therapeutics
- What Does Downgrade Mean in Investing?
- 3 Potential Scenarios to Watch for in D-Wave’s Earnings Report
- What is the Nikkei 225 index?
- Eli Lilly Posts Stellar Q3: Long-Term Upside Is Well in Play
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- Uber Is Crushing Lyft—And It’s Not Even Close
Receive News & Ratings for Emerald Health Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Emerald Health Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
